» Articles » PMID: 15577820

IL-17 Cytokine Family

Overview
Date 2004 Dec 4
PMID 15577820
Citations 105
Authors
Affiliations
Soon will be listed here.
Abstract

A new family of cytokines, IL-17, has recently been defined that reveals a distinct ligand-receptor signaling system. Functional studies have provided evidence for its importance in the regulation of immune responses. Notably, 3 members, IL-17A, IL-17E (IL-25), and IL-17F, have been best characterized both in vitro and in vivo , and have been shown to be proinflammatory in nature. This proinflammatory activity is exemplified by their involvement in pulmonary inflammatory responses, in which both IL-17A and IL-17F are involved in the recruitment of neutrophils, and IL-17E is able to induce T H 2 cytokine production and eosinophilia. Although the elucidation of a detailed mechanism of action continues to be an active area of research, the potent inflammatory activity and its association with various human disease states suggest this new cytokine family as an important contributor to the pathophysiology of human disease conditions, in particular the pulmonary diseases.

Citing Articles

Clinical and Pathophysiological Tangles Between Allergy and Autoimmunity: Deconstructing an Old Dichotomic Paradigm.

Ramirez G, Cardamone C, Lettieri S, Fredi M, Mormile I Clin Rev Allergy Immunol. 2025; 68(1):13.

PMID: 39932658 PMC: 11814061. DOI: 10.1007/s12016-024-09020-3.


Paradoxical Behçet's Disease after Ixekizumab: A Case Report and Literature Review.

Ren Y, Ren L, Sun W, Liu H, Guo S Indian J Dermatol. 2025; 70(1):42-46.

PMID: 39896301 PMC: 11784972. DOI: 10.4103/ijd.ijd_719_24.


IL-17 in wound repair: bridging acute and chronic responses.

Mu X, Gu R, Tang M, Wu X, He W, Nie X Cell Commun Signal. 2024; 22(1):288.

PMID: 38802947 PMC: 11129447. DOI: 10.1186/s12964-024-01668-w.


An elevated level of interleukin-17A in a Senegalese malaria cohort is associated with rs8193038 IL-17A genetic variant.

Thiam F, Diop G, Coulonges C, Derbois C, Thiam A, Diouara A BMC Infect Dis. 2024; 24(1):275.

PMID: 38438955 PMC: 10910704. DOI: 10.1186/s12879-024-09149-8.


Targeting Interleukin-17 as a Novel Treatment Option for Fibrotic Diseases.

Sisto M, Lisi S J Clin Med. 2024; 13(1).

PMID: 38202170 PMC: 10780256. DOI: 10.3390/jcm13010164.